Free Trial

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Share Price Crosses Above Two Hundred Day Moving Average - Should You Sell?

NorthWest Health Prop Real Est Inv Trust logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Shares crossed above their 200-day moving average (C$5.35) on Friday, trading as high as C$5.43 and last at C$5.34 on volume of 869,768, while the 50-day MA remains higher at C$5.71.
  • Analysts have a consensus rating of Hold with a target of C$6.20; RBC raised its target to C$6.00 and ATB Cormark downgraded the stock to "sector perform" with a C$6.25 target.
  • Fundamentals are weak — the company reported C($0.16) EPS last quarter, a negative ROE (-14.67%) and net margin (-75.29%), high debt-to-equity (129.42) and low liquidity (current ratio 0.25), which may limit upside despite the technical breakout.
  • MarketBeat previews the top five stocks to own by May 1st.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report) shares crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of C$5.35 and traded as high as C$5.43. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.34, with a volume of 869,768 shares changing hands.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. ATB Cormark Capital Markets lowered NorthWest Health Prop Real Est Inv Trust from an "outperform" rating to a "sector perform" rating and set a C$6.25 price target on the stock. in a research report on Friday, February 27th. Royal Bank Of Canada raised their price objective on NorthWest Health Prop Real Est Inv Trust from C$5.50 to C$6.00 and gave the stock a "sector perform" rating in a research note on Wednesday, March 4th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, NorthWest Health Prop Real Est Inv Trust currently has an average rating of "Hold" and a consensus target price of C$6.20.

Get Our Latest Analysis on NorthWest Health Prop Real Est Inv Trust

NorthWest Health Prop Real Est Inv Trust Trading Down 2.2%

The firm has a market cap of C$1.33 billion, a P/E ratio of -25.26, a price-to-earnings-growth ratio of 0.74 and a beta of 1.63. The business's fifty day moving average is C$5.71 and its 200-day moving average is C$5.35. The company has a debt-to-equity ratio of 129.42, a quick ratio of 0.06 and a current ratio of 0.25.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report) last posted its quarterly earnings data on Tuesday, February 24th. The company reported C($0.16) earnings per share for the quarter. The firm had revenue of C$102.27 million for the quarter. NorthWest Health Prop Real Est Inv Trust had a negative return on equity of 14.67% and a negative net margin of 75.29%. Analysts predict that NorthWest Health Prop Real Est Inv Trust will post 0.4905498 EPS for the current year.

NorthWest Health Prop Real Est Inv Trust Company Profile

(Get Free Report)

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in NorthWest Health Prop Real Est Inv Trust Right Now?

Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.

While NorthWest Health Prop Real Est Inv Trust currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines